166 related articles for article (PubMed ID: 9829449)
1. Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors.
Paster RZ; Snavely DB; Sweet AR; Draper RA; Goldberg AI; Soffer BA; Sweet CS
Clin Ther; 1998; 20(5):978-89. PubMed ID: 9829449
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of losartan, lisinopril, and metolazone in elderly hypertensive patients with previous angiotensin-converting enzyme inhibitor-induced cough.
Chan P; Tomlinson B; Huang TY; Ko JT; Lin TS; Lee YS
J Clin Pharmacol; 1997 Mar; 37(3):253-7. PubMed ID: 9089428
[TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison of losartan, lisinopril and hydrochlorothiazide in hypertensive patients with a previous angiotensin converting enzyme inhibitor-associated cough.
Ramsay LE; Yeo WW;
J Hypertens Suppl; 1995 Jul; 13(1):S73-6. PubMed ID: 18800460
[TBL] [Abstract][Full Text] [Related]
4. Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group.
Lacourcière Y; Brunner H; Irwin R; Karlberg BE; Ramsay LE; Snavely DB; Dobbins TW; Faison EP; Nelson EB
J Hypertens; 1994 Dec; 12(12):1387-93. PubMed ID: 7706699
[TBL] [Abstract][Full Text] [Related]
5. Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide.
Benz J; Oshrain C; Henry D; Avery C; Chiang YT; Gatlin M
J Clin Pharmacol; 1997 Feb; 37(2):101-7. PubMed ID: 9055135
[TBL] [Abstract][Full Text] [Related]
6. ACE inhibitors, angiotensin II antagonists and cough. The Losartan Cough Study Group.
Ramsay LE; Yeo WW
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S51-4. PubMed ID: 8583482
[TBL] [Abstract][Full Text] [Related]
7. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
Weiss RJ; Stapff M; Lin Y
Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
[TBL] [Abstract][Full Text] [Related]
8. The incidence of cough: a comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist. Telmisartan Cough Study Group.
Lacourciére Y
Int J Clin Pract; 1999 Mar; 53(2):99-103. PubMed ID: 10344043
[TBL] [Abstract][Full Text] [Related]
9. Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study.
Lacourcière Y; Lefebvre J; Nakhle G; Faison EP; Snavely DB; Nelson EB
J Hypertens Suppl; 1994 Jul; 12(2):S49-53. PubMed ID: 7965266
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of losartan compared with atenolol, felodipine and angiotensin converting enzyme inhibitors.
Goldberg AI; Dunlay MC; Sweet CS
J Hypertens Suppl; 1995 Jul; 13(1):S77-80. PubMed ID: 18800461
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the renin-angiotensin-aldosterone system and cough.
Lacourcière Y; Lefebvre J
Can J Cardiol; 1995 Aug; 11 Suppl F():33F-39F. PubMed ID: 7664216
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
Goldberg AI; Dunlay MC; Sweet CS
Am J Cardiol; 1995 Apr; 75(12):793-5. PubMed ID: 7717281
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension.
Tikkanen I; Omvik P; Jensen HA
J Hypertens; 1995 Nov; 13(11):1343-51. PubMed ID: 8984133
[TBL] [Abstract][Full Text] [Related]
14. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
Wu SC; Liu CP; Chiang HT; Lin SL
Heart Vessels; 2004 Jan; 19(1):13-8. PubMed ID: 14685749
[TBL] [Abstract][Full Text] [Related]
15. Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group.
Tanser PH; Campbell LM; Carranza J; Karrash J; Toutouzas P; Watts R
Am J Hypertens; 2000 Feb; 13(2):214-8. PubMed ID: 10701823
[TBL] [Abstract][Full Text] [Related]
16. Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study.
Fogari R; Zoppi A; Carretta R; Veglio F; Salvetti A;
J Hypertens; 2002 May; 20(5):1007-14. PubMed ID: 12011663
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients.
Fogari R; Zoppi A; Corradi L; Lazzari P; Mugellini A; Lusardi P
Br J Clin Pharmacol; 1998 Nov; 46(5):467-71. PubMed ID: 9833600
[TBL] [Abstract][Full Text] [Related]
18. Candesartan Cilexetil is not Associated with Cough in Patients with Enalapril-induced Cough.
Tanser P; Campbell LM; Carranza J; Karrasch J; Toutouzas P; Watts R
Blood Press; 2000; 9(sup1):56. PubMed ID: 28425800
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
Rake EC; Breeze E; Fletcher AE
J Hum Hypertens; 2001 Dec; 15(12):863-7. PubMed ID: 11773989
[TBL] [Abstract][Full Text] [Related]
20. ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema.
Pylypchuk GB
Ann Pharmacother; 1998 Oct; 32(10):1060-6. PubMed ID: 9793599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
